Main
>
ONCOLOGY (**)
>
Breast Cancer>HR+>HER2->MET ***
>
Treatment
>
USA. G. Sacituzumab Govitecan>
>
(*) USA Approval Date: 2023. 02.03
(*) USA Approval Date: 2023. 02.03's products
This section has no products